Title: COPD exacerbations, costs, and health care resource utilization before and after initiation of fluticasone furoate/umeclidinium/vilanterol in routine care in the USA.
Citation: Int J Chron Obstruct Pulmon Dis
2023;18:407–418.
Country: USA | Indication: COPD
Scan to access the publication or visit
http://tago.ca/36998390
http://tago.ca/36998390